Intrauterine contraceptive devices are most generally known as IUDs/IUCDs. These devices are infused into the uterus by specialists and other medicinal professionals to anticipate contraception, by either immobilizing the sperms on their way to the fallopian tubes or by changing the uterine coating, so that the prepared egg can’t be inserted in it. The generally utilized IUCD device is a ‘T’- mold device. The vertical arm has a copper wire wrapped around it, because of which this device is known as Copper T. Also, there are two hued nylon strings at the lower end of the flat arm. The hormone-discharging IUCDs accessible in the market are reasonable for ladies with uncommon necessities. These devices are 99% solid in stopping pregnancy.
How Big is the Global Intra-Uterine Contraceptive Devices Market?
The Global Intra-Uterine Contraceptive Devices Market is expected to be around US$ 5.70 Billion by 2028 at a CAGR of 3.5% in the given forecast period.
The major driving factors of Global Intra-Uterine Contraceptive Devices Market are as follows:
The restraining factors of Global Intra-Uterine Contraceptive Devices Market are as follows:
The Global Intra-Uterine Contraceptive Devices Market is segmented on the lines of its product type, end user and regional. Based on product type segmentation it covers hormonal IUCD, copper IUCD. Based on end user segmentation it covers hospitals, gynecology clinics, community Healthcare. The Global Intra-Uterine Contraceptive Devices Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for Global Intra-Uterine Contraceptive Devices Marketand related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for Global Intra-Uterine Contraceptive Devices Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets on Global Intra-Uterine Contraceptive Devices Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Bayer Healthcare Ag, Dkt International, Egemen International, Melbea Ag., Teva Pharmaceuticals Industries Ltd, Actavis Plc., Ocon Medical Ltd., Pregna International Limited, Medical Engineering Corporation Sa, Smb Corporation, Meril Life Sciences Pvt. Ltd.Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Global Intra-Uterine Contraceptive Devices Market has been segmented as below:
By Analysis:
By Product Type Analysis:
By Regional Analysis:
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Global Intra-Uterine Contraceptive Devices Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Global Intra-Uterine Contraceptive Devices Market data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our new reports:
Soft Tissue Release System Market
1. INTRODUCTION
1.1 KEY TAKE AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 RESEARCH METHODOLOGY
1.5.1 MARKET SIZE
1.5.2 MARKET SHARE
1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES
1.5.4 KEY DATA POINTS FROM PRIMARY SOURCES
2. RESEARCH METHODOLOGY
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE INTRA-UTERINE CONTRACEPTIVE DEVICES (IUCD) MARKET SIZE
2.2.1. MARKET CRACKDOWN APPROACH
2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
2.2.3. DATA TRIANGULATION
2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES
2.2.6. PORTER’S FIVE FORCES MATRIX
2.3. GLOBAL INTRA-UTERINE CONTRACEPTIVE DEVICESMARKET: RESEARCH SNAPSHOT
2.4. ASSUMPTIONS
3. MARKET OVERVIEW
3.1. DRIVERS
3.2.1. INCREASED RATE OF UNPLANNED PREGNANCIES
3.2.2. RISING NUMBER OF INITIATIVES UNDERTAKEN BY THE PRIVATE FIRMS
3.2.3. FAVOURABLE INSURANCE FOR IUCD’S
3.2.4. GROWING AWARENESS OF CONTRACEPTIVE
3.2.5. GROWING FUNDS AND GRANTS FOR IUCD PRODUCTS
3.2.6. TECHNOLOGICAL ADVANCEMENTS
3.2. RESTRAINTS
3.2.1. HIGH COST OF TREATMENT
3.2.2. THREAT OF CAUSING PELVIC INFLAMMOTORY DISEASE (PID)
3.2.3. THREAT CAUSING EPICTAPIC PREGNANCY
3.2.4. CHANGES IN GOVERNMENT REGULATIONS
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
6. GLOBAL INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, BY PRODUCT TYPE
6.1. OVERVIEW
6.2. HORMONAL IUCD (2013 – 2025)
6.2.1. MARKET VALUE (USD MILLION)
6.2.2. MARKET VOLUME (UNITS SOLD)
6.3. COPPER IUCD (2014 – 2024)
6.3.1. MARKET VALUE (USD MILLION)
6.3.2. MARKET VOLUME (UNITS SOLD)
7. GLOBAL INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, BY GEOGRAPHY
7.1. COUNTRYWISE INTRA-UTERINE CONTRACEPTIVE DEVICES MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
7.1.1. NORTH AMERICA
7.1.1.1. U.S.
7.1.1.2. CANADA
7.1.1.3. MEXICO
7.1.2. EUROPE
7.1.2.1. GERMANY
7.1.2.2. FRANCE
7.1.2.3. U.K.
7.1.2.4. ITALY
7.1.2.5. SPAIN
7.1.2.6. RUSSIA
7.1.2.7. TURKEY
7.1.2.8. BELGIUM
7.1.2.9. NETHERLANDS
7.1.2.10. SWITZERLAND
7.1.2.11. REST OF EUROPE
7.1.3. ASIA-PACIFIC (APAC)
7.1.3.1. JAPAN
7.1.3.2. CHINA
7.1.3.3. SOUTH KOREA
7.1.3.4. INDIA
7.1.3.5. AUSTRALIA
7.1.3.6. SINGAPORE
7.1.3.7. THAILAND
7.1.3.8. MALAYSIA
7.1.3.9. INDONESIA
7.1.3.10. PHILIPPINES
7.1.3.11. REST OF APAC
7.1.4. LATIN AMERICA
7.1.4.1. BRAZIL
7.1.4.2. COLOMBIA
7.1.4.3. ARGENTINA
7.1.4.4. CHILE
7.1.4.5. ECUADOR
7.1.4.6. URUGUAY
7.1.4.7. PARAGUAY
7.1.4.8. PERU
7.1.4.9. BOLIVIA
7.1.4.10. REST OF LATIN AMERICA
7.1.5. MIDDLE EAST AND AFRICA
7.1.5.1. EGYPT
7.1.5.2. SAUDI ARABIA
7.1.5.3. REST OF SOUTH AMERICA
7.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
8. GLOBAL INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET: COMPETITIVE LANDSCAPE
8.1. GLOBAL IUCD MARKET: COMPANY SHARE ANALYSIS
8.2. U.S.IUCD MARKET: COMPANY SHARE ANALYSIS
8.3. EUROPE IUCD MARKET: COMPANY SHARE ANALYSIS
8.4. APAC IUCD MARKET: COMPANY SHARE ANALYSIS
8.5. SOUTH AMERICAIUCD MARKET: COMPANY SHARE ANALYSIS
8.6. MIDDLE EAST AND AFRICA IUCD MARKET: COMPANY SHARE ANALYSIS
8.7. MERGERS & ACQUISITIONS
8.8. NEW PRODUCT DEVELOPMENT & APPROVALS
8.9. EXPANSIONS
8.10. REGULATORY CHANGES
8.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
9. GLOBAL INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, COMPANY PROFILES
9.1. BAYER HEALTHCARE AG
9.1.1 OVERVIEW
9.1.2 SWOT ANALYSIS
9.1.3 PRODUCT PORTFOLIO
9.1.4 REVENUE ANALYSIS
9.1.5 ANALYSTS VIEW
9.2. DKT INTERNATIONAL
9.2.1 OVERVIEW
9.2.2 SWOT ANALYSIS
9.2.3 PRODUCT PORTFOLIO
9.2.4 REVENUE ANALYSIS
9.2.5 ANALYSTS VIEW
9.3. TEVA PHARMACEUTICALS INDUSTRIES, LTD
9.3.1 OVERVIEW
9.3.2 SWOT ANALYSIS
9.3.3 PRODUCT PORTFOLIO
9.3.4 REVENUE ANALYSIS
9.3.5 ANALYST VIEW
9.4. ALLERGEN, PLC
9.4.1 OVERVIEW
9.4.2 SWOT ANALYSIS
9.4.3 PRODUCT PORTFOLIO
9.4.4 REVENUE ANALYSIS
9.4.5 ANALYSTS VIEW
9.5. SMB CORPORATION
9.5.1 OVERVIEW
9.5.2 SWOT ANALYSIS
9.5.3 PRODUCT PORTFOLIO
9.5.4 REVENUE ANALYSIS
9.5.5 ANALYSTS VIEW
9.6. ACTAVIS PLC.
9.6.1 OVERVIEW
9.6.2 SWOT ANALYSIS
9.6.3 PRODUCT PORTFOLIO
9.6.4 REVENUE ANALYSIS
9.6.5 ANALYSTS VIEW
9.7 OCON MEDICAL LTD.
9.7.1 OVERVIEW
9.7.2 SWOT ANALYSIS
9.7.3 PRODUCT PORTFOLIO
9.7.4 REVENUE ANALYSIS
9.7.5 ANALYSTS VIEW
9.8 MONALISA NV
9.8.1 OVERVIEW
9.8.2 SWOT ANALYSIS
9.8.3 PRODUCT PORTFOLIO
9.8.4 REVENUE ANALYSIS
9.8.5 ANALYSTS VIEW
9.9 MEDISAFE DISTRIBUTION, INC.
9.9.1 OVERVIEW
9.9.2 SWOT ANALYSIS
9.9.3 PRODUCT PORTFOLIO
9.9.4 REVENUE ANALYSIS
9.9.5 ANALYSTS VIEW
9.10 MERIL LIFE SCIENCES PVT. LTD.
9.10.1 OVERVIEW
9.10.2 SWOT ANALYSIS
9.10.3 PRODUCT PORTFOLIO
9.10.4 REVENUE ANALYSIS
9.10.5 ANALYSTS VIEW
The Global Intra-Uterine Contraceptive Devices Market has been segmented as below:
By Analysis:
By Product Type Analysis:
By Regional Analysis:
